Clinical Trials Browser

Phase 3 × Disease Progression × Etoposide × Clear all

NCT07008716 2025-06-06

Omitting CTV for Primary Tumor in LS-SCLC

Phase 3 Recruiting

Radiation Injuries, Disease Progression